CTXR Long Put Strategy

CTXR (Citius Pharmaceuticals, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

Citius Pharmaceuticals, Inc. operates as a specialized pharmaceutical firm concentrating on the development and market introduction of critical care products. Its efforts are particularly directed towards anti-infective treatments supporting cancer care, various prescription medications, and pioneering mesenchymal stem cell therapies. The company is actively advancing five unique products within its pipeline: Mino-Lok: An antibiotic lock solution designed to combat catheter-related bloodstream infections by salvaging the infected central venous catheter. Mino-Wrap: A novel liquifying gel-based wrap aimed at minimizing infections associated with tissue expanders following breast reconstructive procedures. Halo-Lido: A topical formulation that blends a corticosteroid with lidocaine, intended to deliver both anti-inflammatory and numbing relief to individuals suffering from hemorrhoids. NoveCite: A mesenchymal stem cell therapy currently under development for treating acute respiratory distress syndrome (ARDS).

CTXR (Citius Pharmaceuticals, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $6.0M, a beta of 0.98 versus the broader market, a 52-week range of 0.476-2.48, average daily share volume of 663K, a public-listing history dating back to 2014, approximately 23 full-time employees. These structural characteristics shape how CTXR stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.98 places CTXR roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.

What is a long put on CTXR?

A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration.

Current CTXR snapshot

As of June 30, 2026, spot at $0.60, ATM IV 17.50%, IV rank 0.00%, expected move 5.02%. The long put on CTXR below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.

Why this long put structure on CTXR specifically: CTXR IV at 17.50% is on the cheap side of its 1-year range, which favors premium-buying structures like a CTXR long put, with a market-implied 1-standard-deviation move of approximately 5.02% (roughly $0.03 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated CTXR expiries trade a higher absolute premium for lower per-day decay. Position sizing on CTXR should anchor to the underlying notional of $0.60 per share and to the trader's directional view on CTXR stock.

CTXR long put setup

The CTXR long put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With CTXR near $0.60, the first option leg uses a $0.60 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed CTXR chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 CTXR shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Put$0.60N/A

CTXR long put risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium.

CTXR long put payoff curve

Modeled P&L at expiration across a range of underlying prices for the long put on CTXR. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use long put on CTXR

Long puts on CTXR hedge an existing long CTXR stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying CTXR exposure being hedged.

CTXR thesis for this long put

The market-implied 1-standard-deviation range for CTXR extends from approximately $0.57 on the downside to $0.63 on the upside. A CTXR long put expresses a directional view that the underlying closes below the strike minus premium at expiration, frequently sized to hedge an existing long CTXR position with one put per 100 shares held. Current CTXR IV rank near 0.00% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on CTXR at 17.50%. As a Healthcare name, CTXR options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to CTXR-specific events.

CTXR long put positions are structurally bearish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. CTXR positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move CTXR alongside the broader basket even when CTXR-specific fundamentals are unchanged. Long-premium structures like a long put on CTXR are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current CTXR chain quotes before placing a trade.

Frequently asked questions

What is a long put on CTXR?
A long put on CTXR is the long put strategy applied to CTXR (stock). The strategy is structurally bearish: A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration. With CTXR stock trading near $0.60, the strikes shown on this page are snapped to the nearest listed CTXR chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are CTXR long put max profit and max loss calculated?
Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium. For the CTXR long put priced from the end-of-day chain at a 30-day expiry (ATM IV 17.50%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a CTXR long put?
The breakeven for the CTXR long put priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current CTXR market-implied 1-standard-deviation expected move is approximately 5.02%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a long put on CTXR?
Long puts on CTXR hedge an existing long CTXR stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying CTXR exposure being hedged.
How does current CTXR implied volatility affect this long put?
CTXR ATM IV is at 17.50% with IV rank near 0.00%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

Related CTXR analysis